NOT-EB-21-027: Notice to Rescind NOT-EB-21-018 Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)

Notice to Rescind NOT-EB-21-018 “Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)”

Notice Number:

NOT-EB-21-027

Key Dates

Release Date:

September 20, 2021

Related Announcements

NOT-EB-21-018 - “Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)” - Rescinded

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

This Notice is being issued to inform recipients that National Institute of Biomedical Imaging and Bioengineering (NIBIB) does not plan to release a Funding Opportunity Announcement (FOA) for Blueprint MedTech Prototype Developer (U18 Clinical Trial Not Allowed) as indicated in notice NOT-EB-21-018. Applicants interested in developing prototypes for the Blueprint MedTech program should contact [email protected].

Therefore, this notice is to rescind NOT-EB-21-018 "Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech Prototype Developer (U18 Clinical Trial Not Allowed)."

Inquiries

Please direct all inquiries to:

Michael B. Wolfson, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4778
Email: [email protected]